Double-Expressor Phenotype (BCL-2/c-MYC Co-expression) of Diffuse Large B-Cell Lymphoma and Its Clinicopathological Correlation

Introduction Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease, the spectrum of which is increasing with time. The 2016 World Health Organization (WHO) update on hematopoietic tumors recognized a prognostic subgroup of DLBCL called double-expressor DLBCL. Double-expressor DLBCL is def...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashmi, Atif A, Iftikhar, Syeda N, Nargus, Gul, Ahmed, Omer, Asghar, Ishaq Azeem, Shirazi, Umme Aiman, Afzal, Anoshia, Irfan, Muhammad, Ali, Javaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937403/
https://www.ncbi.nlm.nih.gov/pubmed/33692924
http://dx.doi.org/10.7759/cureus.13155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937403/
https://www.ncbi.nlm.nih.gov/pubmed/33692924
http://dx.doi.org/10.7759/cureus.13155

Ejemplares similares